AXSM FY 2021 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AXSMAxsome Therapeutics, Inc.

$9B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$125M

Net Income

-$130M

EPS (Diluted)

$-3.47

Cash Flow

Operating Cash Flow

-$108M

Free Cash Flow

-$109M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$88M

Total Liabilities

$72M

Stockholders' Equity

$16M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$125M	-$99M	-25.8%
Net Income	-$130M	-$103M	-26.7%